<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Irreversible damage may occur at reperfusion after sustained <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>AIMS: We investigated the value of <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> A for reducing the <z:mpath ids='MPATH_124'>infarct</z:mpath> size in a model of transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Twenty-seven Sprague-Dawley rats sustained a middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> of one-hour </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> multimodal Magnetic Resonance Imaging (MRI) was used during occlusion to confirm the success of surgery and measure baseline lesion size </plain></SENT>
<SENT sid="4" pm="."><plain>Animals were randomly treated by: (i) intracarotid <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> A (10 mg/kg) 20 mins before middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (pretreatment group); (ii) intracarotid <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> A (10 mg/kg) immediately after reperfusion (post-treatment group); and (iii) intracarotid saline immediately after reperfusion </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Histopathological measurements on day 1 showed a significant reduction of <z:mpath ids='MPATH_124'>infarct</z:mpath> size in the pretreatment group compared to the post-treatment (percentage values of ipsilateral hemispheres: 16 ± 5% vs. 29 ± 11%, P = 0·004) and saline groups (16 ± 5% vs. 42 ± 12%, P = 0·015) </plain></SENT>
<SENT sid="6" pm="."><plain>No significant difference was observed between the post-treatment and saline groups (P = 0·065) </plain></SENT>
<SENT sid="7" pm="."><plain>Behavioural examinations on day 1 showed no significant difference between groups </plain></SENT>
<SENT sid="8" pm="."><plain>Immunohistochemistry showed a statistically significant reduction of microglial cell count in the pretreatment group compared to either saline or <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> A post-treatment groups </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: We conclude that intracarotid <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> A is effective in reducing <z:mpath ids='MPATH_124'>infarct</z:mpath> size when given prior to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e>, but not when administered at reperfusion </plain></SENT>
</text></document>